Related Posts
- BET Inhibitor BMS‑986158 for MF: Phase I/II Trial Results
KEY TAKEAWAYS The phase I/II trial aimed to evaluate the efficacy and safety of BMS-986158,…
- Phase II Trial of SAR439859 Against Endocrine Monotherapy in Pre-and Post-Menopausal
KEY TAKEAWAYS The phase II ACT16105 study aimed to assess the safety and effectiveness of…
- 781 A phase II, open-label trial of bintrafusp alfa (M7824) in subjects with thymoma and thymic carcinoma (trial in progress)
Background Development of immunotherapy for TETs has been challenging due to the rarity of the…